Annual ROA
-34.98%
-4.01%-12.95%
December 31, 2023
Summary
- As of February 8, 2025, OVID annual return on assets is -34.98%, with the most recent change of -4.01% (-12.95%) on December 31, 2023.
- During the last 3 years, OVID annual ROA has risen by +71.75% (+67.23%).
- OVID annual ROA is now -138.51% below its all-time high of 90.83%, reached on December 31, 2021.
Performance
OVID ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-26.15%
-3.44%-15.15%
September 30, 2024
Summary
- As of February 8, 2025, OVID quarterly return on assets is -26.15%, with the most recent change of -3.44% (-15.15%) on September 30, 2024.
- Over the past year, OVID quarterly ROA has increased by +11.03% (+29.67%).
- OVID quarterly ROA is now -125.60% below its all-time high of 102.15%, reached on March 31, 2021.
Performance
OVID Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
OVID ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.9% | +29.7% |
| 3 y3 years | +67.2% | +29.7% |
| 5 y5 years | +67.9% | +29.7% |
OVID ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -138.5% | at low | -139.7% | +29.8% |
| 5 y | 5-year | -138.5% | +67.2% | -125.6% | +80.4% |
| alltime | all time | -138.5% | +67.9% | -125.6% | +80.4% |
Ovid Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -26.15%(+15.1%) |
| Jun 2024 | - | -22.71%(-39.0%) |
| Mar 2024 | - | -37.25%(+0.2%) |
| Dec 2023 | -34.98%(+12.9%) | -37.18%(+11.1%) |
| Sep 2023 | - | -33.47%(+5.7%) |
| Jun 2023 | - | -31.67%(+2.5%) |
| Mar 2023 | - | -30.90%(+0.8%) |
| Dec 2022 | -30.97%(-134.1%) | -30.66%(-16.5%) |
| Sep 2022 | - | -36.72%(+6.6%) |
| Jun 2022 | - | -34.45%(+4.2%) |
| Mar 2022 | - | -33.05%(-150.2%) |
| Dec 2021 | 90.83%(-185.1%) | 65.83%(-13.8%) |
| Sep 2021 | - | 76.38%(-2.3%) |
| Jun 2021 | - | 78.18%(-23.5%) |
| Mar 2021 | - | 102.15%(-186.5%) |
| Dec 2020 | -106.73% | -118.04%(+8.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | -108.72%(-18.4%) |
| Jun 2020 | - | -133.30%(+19.0%) |
| Mar 2020 | - | -112.01%(+12.6%) |
| Dec 2019 | -74.79%(-31.4%) | -99.48%(-7.4%) |
| Sep 2019 | - | -107.46%(+17.0%) |
| Jun 2019 | - | -91.84%(+6.2%) |
| Mar 2019 | - | -86.47%(+6.2%) |
| Dec 2018 | -109.09%(+50.6%) | -81.43%(+20.9%) |
| Sep 2018 | - | -67.36%(+21.2%) |
| Jun 2018 | - | -55.56%(+18.6%) |
| Mar 2018 | - | -46.83%(-38.2%) |
| Dec 2017 | -72.44%(+71.4%) | -75.74%(-5.7%) |
| Sep 2017 | - | -80.32%(-3.6%) |
| Jun 2017 | - | -83.32%(-21.2%) |
| Mar 2017 | - | -105.70%(+150.1%) |
| Dec 2016 | -42.27%(+126.0%) | -42.27% |
| Dec 2015 | -18.70% | - |
FAQ
- What is Ovid Therapeutics annual return on assets?
- What is the all time high annual ROA for Ovid Therapeutics?
- What is Ovid Therapeutics annual ROA year-on-year change?
- What is Ovid Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Ovid Therapeutics?
- What is Ovid Therapeutics quarterly ROA year-on-year change?
What is Ovid Therapeutics annual return on assets?
The current annual ROA of OVID is -34.98%
What is the all time high annual ROA for Ovid Therapeutics?
Ovid Therapeutics all-time high annual return on assets is 90.83%
What is Ovid Therapeutics annual ROA year-on-year change?
Over the past year, OVID annual return on assets has changed by -4.01% (-12.95%)
What is Ovid Therapeutics quarterly return on assets?
The current quarterly ROA of OVID is -26.15%
What is the all time high quarterly ROA for Ovid Therapeutics?
Ovid Therapeutics all-time high quarterly return on assets is 102.15%
What is Ovid Therapeutics quarterly ROA year-on-year change?
Over the past year, OVID quarterly return on assets has changed by +11.03% (+29.67%)